Literature DB >> 35257247

Associations between inflammation-related LL-37 with subgingival microbial dysbiosis in rheumatoid arthritis patients.

Chia Wei Cheah1, Anis Rageh Al-Maleki2, Rathna Devi Vaithilingam3, Jamuna Vadivelu2, Sargunan Sockalingam4, Nor Adinar Baharuddin1, Peter Mark Bartold5.   

Abstract

OBJECTIVE: This study investigated the subgingival microbial profile of rheumatoid arthritis (RA) patients and its associations with disease parameters and the inflammation-related antimicrobial peptide, LL-37.
METHODS: RA and non-RA (NRA) patients were assessed for periodontal status and divided into periodontitis (CP), gingivitis (G), and healthy (H) groups. Subgingival plaque 16s rRNA gene sequencing data was processed and analyzed using the CLC Genomic Workbench (Qiagen). Bacterial diversity and co-occurrence patterns were examined. Differential abundance between groups was also investigated. Associations between bacterial genera with disease parameters and LL-37 levels were explored qualitatively using canonical correlation analysis.
RESULTS: Subgingival microbial community clustered in CP status. Co-occurrence network in NRA-H was dominated by health-associated genera, while the rest of the networks' key genera were both health- and disease-associated. RA-CP displayed highly inter-generic networks with a statistically significant increase in periodontal disease-associated genera (p<0.05). In NRA-H, disease parameters and LL-37 were correlated positively with disease-associated genera while negatively with health-associated genera. However, in the remaining groups, mixed positive and negative correlations were noted with genera.
CONCLUSION: RA patients demonstrated subgingival microbial dysbiosis where the bacteria networks were dominated by health- and disease-associated genera. Mixed correlations with disease parameters and LL-37 levels were noted. CLINICAL RELEVANCE: The subgingival microbial dysbiosis in RA may predispose these patients to developing periodontal inflammation with an associated detrimental effect on host immune responses. Routine periodontal assessment may allow initiation of treatment strategies to minimize the effects of gingival inflammation on the existing heightened immune response present in RA patients.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Dysbiosis; Inflammation; LL-37; Rheumatoid arthritis; Subgingival microbial

Mesh:

Substances:

Year:  2022        PMID: 35257247     DOI: 10.1007/s00784-022-04388-y

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  44 in total

Review 1.  Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction.

Authors:  V Michael Holers; M Kristen Demoruelle; Kristine A Kuhn; Jane H Buckner; William H Robinson; Yuko Okamoto; Jill M Norris; Kevin D Deane
Journal:  Nat Rev Rheumatol       Date:  2018-09       Impact factor: 20.543

Review 2.  Clinical and public health implications of periodontal and systemic diseases: An overview.

Authors:  Robert J Genco; Mariano Sanz
Journal:  Periodontol 2000       Date:  2020-06       Impact factor: 7.589

Review 3.  Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis.

Authors:  Elliot D Rosenstein; Robert A Greenwald; Laura J Kushner; Gerald Weissmann
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

Review 4.  Periodontitis: from microbial immune subversion to systemic inflammation.

Authors:  George Hajishengallis
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

Review 5.  Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.

Authors:  Natalia Wegner; Karin Lundberg; Andrew Kinloch; Benjamin Fisher; Vivianne Malmström; Marc Feldmann; Patrick J Venables
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

Review 6.  Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review.

Authors:  Frank A Scannapieco; Renee B Bush; Susanna Paju
Journal:  Ann Periodontol       Date:  2003-12

7.  Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis.

Authors:  Oliver Laugisch; Alicia Wong; Aneta Sroka; Tomasz Kantyka; Joanna Koziel; Klaus Neuhaus; Anton Sculean; Patrick J Venables; Jan Potempa; Burkhard Möller; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2015-08-13       Impact factor: 3.573

Review 8.  Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence.

Authors:  Wenche S Borgnakke; Pekka V Ylöstalo; George W Taylor; Robert J Genco
Journal:  J Periodontol       Date:  2013-04       Impact factor: 6.993

9.  Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases.

Authors:  Maurizio S Tonetti; Thomas E Van Dyke
Journal:  J Periodontol       Date:  2013-04       Impact factor: 6.993

Review 10.  Periodontitis in systemic rheumatic diseases.

Authors:  Paola de Pablo; Iain L C Chapple; Christopher D Buckley; Thomas Dietrich
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

View more
  2 in total

1.  Titanium Surface Characteristics Induce the Specific Reprogramming of Toll-like Receptor Signaling in Macrophages.

Authors:  Zaira González-Sánchez; Victoria Areal-Quecuty; Alvaro Jimenez-Guerra; Daniel Cabanillas-Balsera; Francisco Javier Gil; Eugenio Velasco-Ortega; David Pozo
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

2.  Subgingival Microbiome in Rheumatoid Arthritis Patients with Periodontitis.

Authors:  Yi-Jing Chen; Wei-Chun Hung; Yu-Hsiang Chou; Chern-Hsiung Lai; Po Peng; Pei-Syuan Jhou; Min-Ru Tsai; Jim Jinn-Chyuan Sheu; Jeng-Hsien Yen
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.